| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(qNMR) | min. 98.0 % |
| Melting point | 128.0 to 132.0 °C |
| Specific rotation | -60.0 to -66.0 deg(C=0.6, CHCl3) |
| NMR | confirm to structure |
Active Pharmaceutical Ingredients
Isavuconazole
4-[2-[(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]thiazol-4-yl]benzonitrile; (2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
| Purity / Analysis Method | >98.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C22H17F2N5OSÂ = 437.47 |
| Storage Temperature | Refrigerated (0-10°C) |
| CAS RN | 241479-67-4 |
| Unit | Price |
| 250 mg | 5500 |
| 1 g | 9000 |
| 5 g | 17500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|




